Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$442M |
| 2 |
Deutsche Bank
DB
|
+$410M |
| 3 |
Bank of America
BAC
|
+$395M |
| 4 |
Exxon Mobil
XOM
|
+$332M |
| 5 |
Starbucks
SBUX
|
+$269M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.39B |
| 2 |
Meta Platforms (Facebook)
META
|
+$460M |
| 3 |
Microsoft
MSFT
|
+$376M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$369M |
| 5 |
Broadcom
AVGO
|
+$350M |
Sector Composition
| 1 | Technology | 28.94% |
| 2 | Healthcare | 13.14% |
| 3 | Financials | 12.11% |
| 4 | Communication Services | 9.1% |
| 5 | Consumer Discretionary | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
3001
DELISTED
R1 RCM Inc. Common Stock
RCM
| $110K | ﹤0.01% |
8,737
-329
| -4% | -$4.13K |
|
3002
Fate Therapeutics
FATE
$115M
| $110K | ﹤0.01% |
33,453
-6,529
| -16% | -$21.4K |
|
3003
Heron Therapeutics
HRTX
$236M
| $110K | ﹤0.01% |
31,316
-12,549
| -29% | -$43.9K |
|
|
AGEN
3004
Agenus
AGEN
$145M
| $109K | ﹤0.01% |
6,512
-1,836
| -22% | -$30.8K |
|
3005
Cerus
CERS
$249M
| $109K | ﹤0.01% |
61,709
-20,004
| -24% | -$35.2K |
|
3006
Cardlytics
CDLX
$146M
| $108K | ﹤0.01% |
13,208
-15,037
| -53% | -$123K |
|
3007
Cambium Networks
CMBM
$21.2M
| $108K | ﹤0.01% |
38,809
-404
| -1% | -$1.13K |
|
|
THRD
3008
DELISTED
Third Harmonic Bio
THRD
| $108K | ﹤0.01% |
+8,273
| New | +$108K |
|
3009
Achieve Life Sciences
ACHV
$147M
| $107K | ﹤0.01% |
+22,865
| New | +$107K |
|
3010
Atea Pharmaceuticals
AVIR
$236M
| $107K | ﹤0.01% |
32,449
-7,941
| -20% | -$26.3K |
|
3011
PepGen
PEPG
$67.2M
| $107K | ﹤0.01% |
6,725
+2,496
| +59% | +$39.8K |
|
3012
MBIA
MBI
$379M
| $106K | ﹤0.01% |
19,267
-4,368
| -18% | -$24K |
|
3013
Bel Fuse Class A
BELFA
$1.58B
| $106K | ﹤0.01% |
+1,306
| New | +$106K |
|
3014
Anavex Life Sciences
AVXL
$745M
| $105K | ﹤0.01% |
24,993
-12,782
| -34% | -$53.9K |
|
3015
Cabaletta Bio
CABA
$199M
| $105K | ﹤0.01% |
14,018
-3,792
| -21% | -$28.4K |
|
3016
Black Diamond Therapeutics
BDTX
$191M
| $104K | ﹤0.01% |
+22,388
| New | +$104K |
|
3017
Lufax Holding
LU
$2.78B
| $104K | ﹤0.01% |
44,001
+5,156
| +13% | +$12.2K |
|
3018
Frontier Group Holdings
ULCC
$1.2B
| $104K | ﹤0.01% |
21,120
-896
| -4% | -$4.42K |
|
3019
Bit Digital
BTBT
$1B
| $104K | ﹤0.01% |
32,574
-6,963
| -18% | -$22.1K |
|
3020
Nkarta
NKTX
$141M
| $103K | ﹤0.01% |
17,463
-2,542
| -13% | -$15K |
|
3021
AerSale
ASLE
$409M
| $103K | ﹤0.01% |
14,885
+4,046
| +37% | +$28K |
|
3022
iShares Russell 2000 Growth ETF
IWO
$13.1B
| $102K | ﹤0.01% |
388
-5
| -1% | -$1.31K |
|
3023
Janus Henderson AAA CLO ETF
JAAA
$25.2B
| $101K | ﹤0.01% |
+1,994
| New | +$101K |
|
3024
Silvercrest Asset Management
SAMG
$139M
| $101K | ﹤0.01% |
6,488
-323
| -5% | -$5.04K |
|
3025
Genesco
GCO
$381M
| $100K | ﹤0.01% |
3,880
-1,186
| -23% | -$30.7K |
|